Allen & Overy advises Novartis on $28bn Alcon acquisition

January 5, 2010 Allen & Overy is advising pharma giant Novartis on its $28bn acquisition of a majority stake in eye-care company Alcon, with a team led by Eric Shube.

US firms Wachtell Lipton Rosen & Katz, Cravath Swaine & Moore and Sullivan & Cromwell also won major roles on the deal, reports The Am Law Daily.


comments powered by Disqus